157
Views
17
CrossRef citations to date
0
Altmetric
Original Articles

Induction of Resistance to the Lipophilic Cytarabine Prodrug Elacytarabine (CP-4055) in CEM Leukemic Cells

, , , , , & show all
Pages 394-399 | Published online: 11 Jun 2010

REFERENCES

  • Hubeek , I. , Kaspers , G. J. , Ossenkoppele , G. J. and Peters , G. J. 2006 . Cancer Drug Discovery and Development: Deoxynucleoside Analogs in Cancer Therapy , Edited by: Peters , G. J. 119 – 152 . Totowa, NJ : Humana Press inc. .
  • Mackey , J. R. , Mani , R. S. , Selner , M. , Mowles , D. , Young , J. D. , Belt , J. A. , Crawford , C. R. and Cass , C. E. 1998 . Functional nucleoside transporters are required for gemcitabine influx and manifestation of toxicity in cancer cell lines . Cancer Res. , 58 : 4349 – 4357 .
  • Bergman , A. M. , Pinedo , H. M. and Peters , G. J. 2002 . Determinants of resistance to 2′,2′-difluorodeoxycytidine (gemcitabine) . Drug Resist. Updat. , 5 : 19 – 33 .
  • Plunkett , W. and Gandhi , V. 1993 . Cellular pharmacodynamics of anticancer drugs . Semin. Oncol. , 20 : 50 – 63 .
  • Breistol , K. , Balzarini , J. , Sandvold , M. L. , Myhren , F. , Martinsen , M. , De Clercq , E. and Fodstad , O. 1999 . Antitumor activity of P-4055 (elaidic acid-cytarabine) compared to cytarabine in metastatic and s.c. human tumor xenograft models . Cancer Res. , 59 : 2944 – 2949 .
  • Bergman , A. M. , Kuiper , C. M. , Voorn , D. A. , Comijn , E. M. , Myhren , F. , Sandvold , M. L. , Hendriks , H. R. and Peters , G. J. 2004 . Antiproliferative activity and mechanism of action of fatty acid derivatives of arabinofuranosylcytosine in leukemia and solid tumor cell lines . Biochem. Pharmacol. , 67 : 503 – 511 .
  • Bergman , A. M. , Kuiper , C. M. , Myhren , F. , Sandvold , M. L. , Hendriks , H. R. and Peters , G. J. 2004 . Antiproliferative activity and mechanism of action of fatty acid derivatives of arabinosylcytosine (ara-C) in leukemia and solid tumor cell lines . Nucleosides Nucleotides Nucleic Acids , 23 : 1523 – 1526 .
  • Bergman , A. M. , Kuiper , C. M. , Noordhuis , P. , Smid , K. , Voorn , D. A. , Comijn , E. M. , Myhren , F. , Sandvold , M. L. , Hendriks , H. R. , Fodstad , O. , Breistol , K. and Peters , G. J. 2004 . Antiproliferative activity and mechanism of action of fatty acid derivatives of gemcitabine in leukemia and solid tumor cell lines and in human xenografts . Nucleosides Nucleotides Nucleic Acids , 23 : 1329 – 1333 .
  • Dueland , S. , Aamdal , S. , Lind , M. J. , Thomas , H. , Sandvold , M. L. , Gaullier , J. M. and Rasch , W. 2008 . Intravenous administration of CP-4055 (ELACYTtrade mark) in patients with solid tumours. A phase I study . Acta Oncol. , 48 : 137 – 145 .
  • Belt , J. A. , Marina , N. M. , Phelps , D. A. and Crawford , C. R. 1993 . Nucleoside transport in normal and neoplastic cells . Adv. Enzyme Regul. , 33 : 235 – 252 .
  • Noordhuis , P. , Kazemier , K. M. , Kaspers , G. J. and Peters , G. J. 1996 . Modulation of metabolism and cytotoxicity of cytosine arabinoside with N-(phosphon)-acetyl-L-aspartate in human leukemic blast cells and cell lines . Leuk. Res. , 20 : 127 – 134 .
  • Sigmond , J. , Kroep , J. R. , Loves , W. , Codacci-Pisanelli , G. and Peters , G. J. 2004 . Quantitative real time PCR of deoxycytidine kinase mRNA by Light Cycler PCR in relation to enzyme activity and gemcitabine sensitivity . Cancer Lett. , 213 : 173 – 179 .
  • Galmarini , C. M. , Myhren , F. and Sandvold , M. L. 2008 . CP-4055 and CP-4126 are active in ara-C and gemcitabine-resistant lymphoma cell lines . Br. J. Haematol. , 144 : 273 – 275 .
  • Ruiz van Haperen , V. , Veerman , G. , Eriksson , S. , Boven , E. , Stegmann , A. P. , Hermsen , M. , Vermorken , J. B. , Pinedo , H. M. and Peters , G. J. 1994 . Development and molecular characterization of a 2′,2′-difluorodeoxycytidine-resistant variant of the human ovarian carcinoma cell line A2780 . Cancer Res. , 54 : 4138 – 4143 .
  • Bergman , A. M. , Eijk , P. P. , Ruiz van Haperen , V. , Smid , K. , Veerman , G. , Hubeek , I. , van den IJssel , P. , Ylstra , B. and Peters , G. J. 2005 . In vivo induction of resistance to gemcitabine results in increased expression of ribonucleotide reductase subunit M1 as the major determinant . Cancer Res. , 65 : 9510 – 9516 .

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.